Blood-brain barrier (BBB) dysfunction has been found in multiple neurodegenerative conditions, including mild cognitive impairment (MCI) and Alzheimer’s disease (AD). However recent concerns on the repeated use of Gadolinium based contrast agents (GBCAs), prompted us to investigate alternative, non-invasive methods for measuring BBB function. Both diffusion-weighted (DW) and multi-echo (ME) ASL was implemented at 3T to determine water transfer rates (kw) in the brain in MCI and early AD participants. We found kw to be lower in the cognitively impaired group, compared to controls, with both modalities, suggesting that these techniques may provide a marker of early AD pathology.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords